From: Nature and reporting characteristics of UK health technology assessment systematic reviews
Disease area | HTAs 2004 & 2014 | Systematic reviews 2004 [1]a | Systematic reviews 2014 [1]a |
---|---|---|---|
Neoplasms (i.e. cancers, carcinomas, tumours) | 8 (16%) | 22 (7%) | 49 (16%) |
Diseases of the circulatory system | 8 (16%) | 33 (11%) | 34 (11%) |
Endocrine, nutritional or metabolic disease | 7 (14%) | NR | 23 (8%) |
Mental and Behavioural | 5 (10%) | 40 (13%) | 22 (7%) |
Infections and parasitic diseases | 3 (6%) | 22 (7%) | 41 (14%) |
Diseases of the nervous system | 3 (6%) | NR | NR |
Musculoskeletal | 3 (6%) | NR | 20 (7%) |
Diseases of the eye and adnexa | 2 (4%) | NR | NR |
External causes of mortality and morbidity | 2 (4%) | NR | NR |
Genito-urinary | 2 (4%) | NR | NR |
Diseases of the digestive system | 2 (4%) | 20 (7%) | 25 (8%) |
Ear and mastoid process | 1 (2%) | NR | NR |
Pregnancy and birth | 1 (2%) | NR | NR |
Blood | 1 (2%) | NR | NR |
Skin and subcutaneous tissue | 1 (2%) | NR | NR |
Congenital malformations | 1 (2%) | NR | NR |
Total | 50 (100%) | 137b | 214b |